Literature DB >> 18571119

Adiponectin and its association with insulin resistance and type 2 diabetes.

Tianxin Sheng1, Kangjuan Yang.   

Abstract

Adiponectin is an adipokine, which is expressed in adipose tissue and is thought to play an important role in glucose metabolism. Hypoadiponectinemia can cause reduction of fatty acid oxidation, decreased glucose uptake in skeletal muscle cells, and increased gluconeogenesis in hepatic cells. The level of plasma glucose can be increased. On the other hand, the decrease of fatty acid oxidation increases the level of free fatty acid (FFA), which increases the insulin resistance, and then decreases the glucose uptake, which ultimately causes increased plasma glucose and type 2 diabetes (T2D). This review describes the process from hypoadiponectinemia to T2D and the genesis of hypoadiponectinemia at a molecular level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571119     DOI: 10.1016/S1673-8527(08)60047-8

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  35 in total

1.  Genetic effects of adiponectin single nucleotide polymorphisms on the clustering of metabolic risk factors in young Korean adults.

Authors:  Ji-Young Lee; Jin-Kyung Cho; Hye-Ryun Hong; Young-Yoon Jin; Hyun-Sik Kang
Journal:  Eur J Appl Physiol       Date:  2011-06-01       Impact factor: 3.078

2.  A low-fat high-carbohydrate diet reduces plasma total adiponectin concentrations compared to a moderate-fat diet with no impact on biomarkers of systemic inflammation in a randomized controlled feeding study.

Authors:  Xiaoling Song; Mark Kestin; Yvonne Schwarz; Pamela Yang; Xiaojun Hu; Johanna W Lampe; Mario Kratz
Journal:  Eur J Nutr       Date:  2015-02-04       Impact factor: 5.614

3.  No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: a randomized double-blinded, placebo-controlled crossover trial.

Authors:  Verena Brüll; Constanze Burak; Birgit Stoffel-Wagner; Siegfried Wolffram; Georg Nickenig; Cornelius Müller; Peter Langguth; Birgit Alteheld; Rolf Fimmers; Peter Stehle; Sarah Egert
Journal:  Eur J Nutr       Date:  2016-07-16       Impact factor: 5.614

Review 4.  Adiponectin serum level in chronic hepatitis C infection and therapeutic profile.

Authors:  Valentina Peta; Carlo Torti; Natasa Milic; Alfredo Focà; Ludovico Abenavoli
Journal:  World J Hepatol       Date:  2015-01-27

5.  Hypoglycemic and hypolipidemic effects of samnamul (shoot of Aruncus dioicus var. kamtschaticus Hara) in mice fed a high-fat/high-sucrose diet.

Authors:  Jung-In Kim; Jeong-A Yun; Yoo-Kyung Jeong; Hee-Jin Baek
Journal:  Food Sci Biotechnol       Date:  2018-06-08       Impact factor: 2.391

Review 6.  The therapeutic potential of GPR43: a novel role in modulating metabolic health.

Authors:  Lauren M Cornall; Michael L Mathai; Deanne H Hryciw; Andrew J McAinch
Journal:  Cell Mol Life Sci       Date:  2013-07-14       Impact factor: 9.261

7.  The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes.

Authors:  Philip L Hooper; Gabor Balogh; Eric Rivas; Kylie Kavanagh; Laszlo Vigh
Journal:  Cell Stress Chaperones       Date:  2014-02-13       Impact factor: 3.667

8.  Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women.

Authors:  Labros Melistas; Christos S Mantzoros; Meropi Kontogianni; Smaragdi Antonopoulou; Jose M Ordovas; Nikos Yiannakouris
Journal:  Eur J Endocrinol       Date:  2009-09-15       Impact factor: 6.664

9.  The aporphine alkaloid boldine induces adiponectin expression and regulation in 3T3-L1 cells.

Authors:  Bangning Yu; Carla Cook; Nalini Santanam
Journal:  J Med Food       Date:  2009-10       Impact factor: 2.786

10.  Associations between two single nucleotide polymorphisms of the adiponectin gene, its circulating concentrations and cardiometabolic risk factors in prepubertal children with and without abdominal obesity.

Authors:  S V Galcheva; D Martorana; V M Iotova; Y Yotov; T M Neri; M E Street
Journal:  J Endocrinol Invest       Date:  2013-05-22       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.